Project Details
Description
Phase II Trial of Velcade + Vorinostat in the Treatment of High Risk MDS and Relapsed/Refractory AML
| Status | Finished |
|---|---|
| Effective start/end date | 1/1/08 → 12/31/13 |
Funding
- MERCK AND CO INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.